Rivermark Medical, Inc.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
2
Funding Rounds
$31.8m
Money raised
Overview
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Rivermark Medical, Inc. has raised a total of $31.75m in funding over 2 rounds.
Key Insights:
- Rivermark Medical October 2024 Series C Funding Round: $30m
- Rivermark Medical, Inc. Funding Round, November 2021: $1.75m
Rivermark Medical October 2024 Series C Funding Round
$30m
Rivermark Medical, Inc. Funding Round, November 2021
$1.75m
Industries
Rivermark Medical, Inc. is active in the following industries: